CD274 and neoplasm: Because PD-L1 expression cannot be used to accurately select patients for PD-1/PD-L1 blockade due to the low prediction accuracy, tumor-infiltrating immune cells and molecules in the tumor microenvironment along with PD-L1 expression may be important in predicting clinical benefits of PD-1/PD-L1 checkpoint blockades [55].